PT-141 nasal spray is a bremelanotide peptide sprayed into the nose. Learn how it works, nasal spray vs injection, side effects, and legal status.
PT-141 nasal spray is a liquid form of bremelanotide, a synthetic peptide that acts on the brain to increase sexual desire instead of increasing blood flow. Users spray it into the nose, where it is absorbed through the nasal lining. No nasal bremelanotide product is FDA-approved for human use in the United States.
What Is PT-141 Nasal Spray?
PT-141 is the research name for bremelanotide, a melanocortin receptor agonist. The FDA approved it in 2019 as Vyleesi, a subcutaneous autoinjector for hypoactive sexual desire disorder (HSDD) in premenopausal women.
The nasal version sits in a different category. It is sold as a compounded preparation or, far more often, as a research-grade vial that users mix into a spray bottle themselves. Because it is not an approved drug, its strength, sterility, and purity are not regulated by the FDA.
Most vendors offering a pt-141 peptide nasal spray ship it as a lyophilized powder with a separate bottle of diluent, along with a label stating it is for laboratory research only.
How PT-141 Works in the Body
Bremelanotide binds to melanocortin receptors, particularly MC4R, in the hypothalamus — the region of the brain that helps regulate appetite, mood, and sexual behavior. Unlike Viagra or Cialis, it does not widen blood vessels; it works upstream on desire signals in the central nervous system.
Effects typically begin 30 to 60 minutes after dosing and can last several hours. In the RECONNECT trials of the injectable, roughly 25 percent of women reported a meaningful increase in desire compared with about 17 percent on placebo, which is a real but modest effect.
Nasal Spray Compared With the Injection
When you line up pt-141 nasal spray vs injection, the differences come down to absorption, dose control, and regulatory oversight.
| Feature | Nasal spray | Subcutaneous injection (Vyleesi) |
|---|---|---|
| FDA status | Not approved | Approved in 2019 for HSDD |
| Typical dose | Varies by vendor; often 1–2 mg per nostril | Fixed 1.75 mg dose |
| Onset | About 30–60 minutes | About 45 minutes |
| Absorption | Lower and inconsistent from person to person | High and predictable |
| Common side effects | Nasal irritation plus systemic nausea, flushing, headache | Nausea, flushing, headache, injection-site reactions |
| Access | Research chemical or compounded product | Prescription only |
The injected form is the only version backed by large clinical trials and a fixed, tested dose. A nasal spray avoids needles, but it trades convenience for unpredictable absorption.
Is PT-141 Nasal Spray Effective?
No large modern trial has tested a nasal bremelanotide spray. Early intranasal formulations were studied in the 2000s, but developers moved to injection because the nasal route produced sharper blood pressure increases and less consistent absorption.
That means most claims about nasal potency come from user reports rather than controlled data. Search pt-141 spray reddit and you will find plenty of anecdotes — some users describe a clear effect within 45 minutes, while others report nothing except nausea and a headache. Sexual desire research is also highly susceptible to the placebo effect, so personal reports should be read with caution.
Safety and Side Effects
Is pt-141 nasal spray safe? The approved injectable has a known risk profile, and the nasal spray adds unregulated dosing on top of it. Nausea is the most common side effect, reported by roughly 40 percent of participants in bremelanotide trials.
Other reported effects include:
- Flushing, headache, and vomiting
- A temporary rise in blood pressure, sometimes within the first hour
- Nasal irritation, congestion, sneezing, or nosebleeds from the spray itself
- Hyperpigmentation — dark patches on the gums, face, or skin — with repeated use, which may not fade after stopping
Prescribing information for Vyleesi advises no more than one dose in 24 hours and no more than eight doses per month. Bremelanotide is not recommended for people with uncontrolled high blood pressure or known cardiovascular disease.
Anyone weighing this peptide should discuss it with a healthcare professional, particularly if they take blood pressure medication, antidepressants, or nitrate drugs.
Buying and Making It: What to Know
Any pt-141 nasal spray for sale online is almost certainly a research chemical, not an approved medicine. Vendors label these vials “not for human consumption,” and independent testing has repeatedly found mislabeled or impure peptides in this market.
People also search how to make pt-141 nasal spray, and forums describe dissolving the powder in bacteriostatic water or saline. A homemade spray means guessing the concentration, using non-sterile equipment, and risking contamination — and it will never match the consistency of a pharmacy-compounded product.
Even a properly compounded nasal spray is not interchangeable with the injection. Dose for dose, the nose delivers less bremelanotide into the bloodstream, and the amount that gets through varies with technique, congestion, and the spray device itself.
The Bottom Line
PT-141 nasal spray is an unapproved, unregulated form of bremelanotide that some people use for sexual desire. The only FDA-approved version is a subcutaneous injection sold as Vyleesi, and even that produces modest benefits with noticeable side effects.
If desire or arousal concerns are affecting your life, a clinician can discuss approved options and screen for underlying causes such as medications, hormones, or mental health conditions. Buying unverified peptides online carries real risk with no guarantee of benefit.
Frequently Asked Questions
Is PT-141 nasal spray FDA-approved?
No. The only FDA-approved bremelanotide product is Vyleesi, a 1.75 mg subcutaneous injection for hypoactive sexual desire disorder in premenopausal women. Nasal sprays sold online are research chemicals or compounded preparations, so their strength, purity, and sterility are not reviewed by the FDA.
How long does PT-141 nasal spray take to work?
Users typically report effects starting 30 to 60 minutes after spraying, lasting several hours. The approved injection begins working in about 45 minutes. Label guidance for bremelanotide limits use to one dose in 24 hours and no more than eight doses per month.
Does PT-141 nasal spray work for men?
Bremelanotide was first studied in men for erectile dysfunction, and early intranasal trials showed some effect, but development shifted to women with HSDD. It is not FDA-approved for men, so any male use would be off-label and unregulated.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.